Protagonist Therapeutics Inc buy BMO Capital Markets
Start price
11.03.25
/
50%
€50.50
Target price
11.03.26
€66.33
Performance (%)
66.34%
End price
12.03.26
€84.00
Summary
This prediction ended on 12.03.26 with a price of €84.00. The BUY prediction by BMO_Capital_Markets for Protagonist Therapeutics Inc saw massive gains of 66.34%. BMO_Capital_Markets has a follow-up prediction for Protagonist Therapeutics Inc where he still thinks Protagonist Therapeutics Inc is a Buy. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Protagonist Therapeutics Inc | 2.542% | 2.542% | 155.274% |
| iShares Core DAX® | 1,72 % | 3,37 % | 5,89 % |
| iShares Nasdaq 100 | -4,56 % | -4,24 % | 21,39 % |
| iShares Nikkei 225® | -7,12 % | -11,87 % | 42,36 % |
| iShares S&P 500 | -0,89 % | 1,69 % | 19,49 % |
Comments by BMO_Capital_Markets for this prediction
In the thread Protagonist Therapeutics Inc diskutieren
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) had its price target raised by analysts at BMO Capital Markets from $62.00 to $72.00. They now have an "outperform" rating on the stock.
Ratings data for PTGX provided by MarketBeat
In the thread Trading Protagonist Therapeutics Inc
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten
Current prediction by BMO_Capital_Markets for Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€75.50
13.10.25
13.10.25
-
13.10.26
13.10.26
60.26%
28.07.26
28.07.26
Stopped prediction by BMO_Capital_Markets for Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€50.50
06.12.24
06.12.24
€58.44
06.12.25
06.12.25
62.38%
07.12.25
07.12.25